Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KYMR Kymera Therapeutics, Inc.

休市中 07-26 16:00:00 EDT

44.54

+0.50

+1.14%

盘后44.54

+0.000.00%

16:20 EDT

最高45.32	最低43.30	成交量39.03万
今开44.70	昨收44.04	日振幅4.59%
总市值27.33亿	流通市值18.07亿	总股本6,136万
成交额1,741万	换手率0.96%	流通股本4,058万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":44.54,"timestamp":1722024000000,"preClose":44.04,"halted":0,"volume":390279,"hourTrading":{"tag":"盘后","latestPrice":44.54,"preClose":44.54,"latestTime":"16:20 EDT","volume":8220,"amount":366118.8,"timestamp":1722025200430},"delay":0,"floatShares":40578188,"shares":61358262,"eps":-2.513212,"marketStatus":"休市中","marketStatusCode":7,"change":0.5,"latestTime":"07-26 16:00:00 EDT","open":44.7,"high":45.32,"low":43.3,"amount":17413831.38147,"amplitude":0.045867,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.513212,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1597982400000,"adjPreClose":44.04,"postHourTrading":{"tag":"盘后","latestPrice":44.54,"preClose":44.54,"latestTime":"16:20 EDT","volume":8220,"amount":366118.8,"timestamp":1722025200430},"volumeRatio":0.6960825372110319,"impliedVol":0.7243,"impliedVolPercentile":0.2619},"requestUrl":"/m/hq/s/KYMR/wiki","defaultTab":"wiki","newsList":[{"id":"2454805924","title":"Kymera Therapeutics, Inc.盘中异动 临近午盘股价大涨5.34%报45.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454805924","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454805924?lang=zh_cn&edition=full","pubTime":"2024-07-25 23:35","pubTimestamp":1721921718,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日23时35分，Kymera Therapeutics, Inc.股票出现异动，股价大幅拉升5.34%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725233518968205a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725233518968205a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2453888868","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453888868","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453888868?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:30","pubTimestamp":1721827840,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日21时30分，Kymera Therapeutics, Inc.股票出现波动，股价急速下跌5.29%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724213040af93e71b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724213040af93e71b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KYMR","BK4139"],"gpt_icon":0},{"id":"2452583224","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452583224","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452583224?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:16","pubTimestamp":1721326585,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时16分，Kymera Therapeutics, Inc.股票出现异动，股价大幅跳水5.17%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.14%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719021625aefa5b8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719021625aefa5b8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2452917622","title":"Kymera Therapeutics, Inc.盘中异动 股价大涨5.36%报47.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452917622","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452917622?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:27","pubTimestamp":1721147252,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时27分，Kymera Therapeutics, Inc.股票出现异动，股价急速拉升5.36%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717002732941f77cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717002732941f77cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2451465629","title":"Kymera Therapeutics, Inc.盘中异动 早盘急速上涨5.01%报44.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451465629","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451465629?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:47","pubTimestamp":1721054822,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时47分，Kymera Therapeutics, Inc.股票出现异动，股价大幅上涨5.01%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715224702941f7122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715224702941f7122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2450397785","title":"Kymera Therapeutics, Inc.盘中异动 早盘大幅拉升5.13%报41.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450397785","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450397785?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:12","pubTimestamp":1720793533,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时12分，Kymera Therapeutics, Inc.股票出现波动，股价大幅拉升5.13%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。消息层面，截至22时12分，《斯迪富维持Kymera Therapeutics买入评级，维持目标价55美元》资讯为影响Kymera Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122212139681c674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122212139681c674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","BK4139","LENZ"],"gpt_icon":0},{"id":"2450813064","title":"Kymera Therapeutics, Inc.盘中异动 急速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450813064","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450813064?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:45","pubTimestamp":1720619104,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时45分，Kymera Therapeutics, Inc.股票出现波动，股价快速下挫5.55%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。消息层面，截至21时45分，《斯迪富维持Kymera Therapeutics买入评级，维持目标价55美元》资讯为影响Kymera Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102145059681b8bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102145059681b8bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KYMR"],"gpt_icon":0},{"id":"2450028933","title":"Kymera Therapeutics, Inc.股价拉升11.31% 市值涨2.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450028933","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450028933?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:33","pubTimestamp":1720531981,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时33分，Kymera Therapeutics, Inc.股票出现波动，股价急速拉升11.31%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。消息层面，截至21时33分，《斯迪富维持Kymera Therapeutics买入评级，维持目标价55美元》资讯为影响Kymera Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092133019f25b705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ","BK4139"],"gpt_icon":0},{"id":"2450060385","title":"美国研究综述-Alphabet、多米诺比萨、McKesson","url":"https://stock-news.laohu8.com/highlight/detail?id=2450060385","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450060385?lang=zh_cn&edition=full","pubTime":"2024-07-09 14:49","pubTimestamp":1720507794,"startTime":"0","endTime":"0","summary":"    路透7月9日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Alphabet、Domino's Pizza 和 McKesson。要闻             * Alphabet Inc   ：杰富瑞将目标价从215美元上调至220美元             * Domino's Pizza Inc   ：贝尔德上调其评级至 \"跑赢大盘\"，目标价从530美元上调至580美元              * McKesson Corp   ：贝雅将目标价从679美元上调至694美元              * Teleflex Inc   ：Truist Securities将目标价从219美元上调至235美元             * Tradeweb Markets Inc   ：Raymond James将目标价从115美元上调至117美元  以下是路透周二报道的美国公司研究报告摘要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVN","LU0889566641.SGD","EWTX","CAH","BK4585","BK4588","BK4112","LU0494093205.USD","BK4141","CGC","BK4503","BK4576","LU1430594728.SGD","ACM","LU0149725797.USD","BK4579","LU0006061336.USD","DYN","MCK","BK4023","LU0048573561.USD","LU2087625088.SGD","LU0320765059.SGD","GOOGL","LU0310800965.SGD","LU0170899867.USD","LU1267930730.SGD","TW","ZETA","TEM","IE00BJTD4V19.USD","LU0310800379.SGD","DPZ","EPR","TFX","LU2125154778.USD","CMG","LU0127658192.USD","SGXZ81514606.USD","SIMO","LU0742534661.SGD","CRNX","KYMR","IE00BKVL7J92.USD","DIN","LU1983260115.SGD","SG9999004303.SGD","LU0211328371.USD","LU2065169927.USD","COR"],"gpt_icon":0},{"id":"1193988402","title":"美股夜盘 | 英特尔涨超2%，此前已录得四连涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1193988402","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1193988402?lang=zh_cn&edition=full","pubTime":"2024-07-09 08:33","pubTimestamp":1720485197,"startTime":"0","endTime":"0","summary":"英特尔涨超2%，该股隔夜收涨超6%，已连续第四个交易日上涨，为2024年5月16日以来的最长连涨期。","market":"us","thumbnail":"https://static.tigerbbs.com/18f26a21557b2b9fbf841d276ecb7796","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/18f26a21557b2b9fbf841d276ecb7796"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTC","NVDA","KYMR","TSLA","AAPL"],"gpt_icon":0},{"id":"2450295080","title":"BUZZ-Kymera 公司崛起，合作伙伴赛诺菲将扩大炎症性疾病药物的试验范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2450295080","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450295080?lang=zh_cn&edition=full","pubTime":"2024-07-09 04:58","pubTimestamp":1720472326,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月8日 - ** Kymera Therapeutics   股价盘后上涨12.6%，报36美元 ** 该药物开发商称其合作伙伴赛诺菲  计划扩大正在进行的中期研究，该实验性药物将用于治疗慢性炎症性皮肤病--化脓性扁桃体炎，以及导致皮肤发炎、发红和刺激的特应性皮炎或湿疹。 ** 候选药物KT-474以IRAK4蛋白为靶标，该蛋白负责引发炎症，以对抗感染** 赛诺菲以 1.5 亿美元的预付款和价值超过 20 亿美元的付款，获得了 (link) 全球开发 KYMR IRAK4 蛋白降解剂的权利。** 截至上日收盘，股价累计上涨约 26","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2450608605","title":"Kymera Therapeutics, Inc.盘中异动 大幅上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450608605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450608605?lang=zh_cn&edition=full","pubTime":"2024-07-09 02:12","pubTimestamp":1720462321,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日02时12分，Kymera Therapeutics, Inc.股票出现波动，股价快速拉升5.12%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709021201aef87e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709021201aef87e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2448944148","title":"Kymera Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.26%报31.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448944148","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448944148?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:34","pubTimestamp":1719862480,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时34分，Kymera Therapeutics, Inc.股票出现异动，股价急速拉升5.26%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702033441941f2cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702033441941f2cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","BK4139","LENZ"],"gpt_icon":0},{"id":"2444113732","title":"Kymera Therapeutics, Inc.盘中异动 股价大跌5.08%报31.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444113732","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444113732?lang=zh_cn&edition=full","pubTime":"2024-06-18 02:34","pubTimestamp":1718649249,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日02时34分，Kymera Therapeutics, Inc.股票出现异动，股价急速跳水5.08%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。消息层面，截至02时34分，《派杰投资维持Kymera Therapeutics买入评级，维持目标价56美元》资讯为影响Kymera Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618023410af8de6e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618023410af8de6e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2442232554","title":"Kymera Therapeutics, Inc.盘中异动 早盘急速拉升5.44%报36.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442232554","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442232554?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199111,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Kymera Therapeutics, Inc.股票出现异动，股价大幅上涨5.44%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221315196813b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221315196813b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2435177125","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435177125","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435177125?lang=zh_cn&edition=full","pubTime":"2024-05-14 23:11","pubTimestamp":1715699476,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日23时11分，Kymera Therapeutics, Inc.股票出现波动，股价急速跳水5.14%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142311177a59db6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142311177a59db6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0},{"id":"2432970247","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报38.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432970247","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432970247?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:39","pubTimestamp":1714743564,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时39分，Kymera Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032139257925c0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032139257925c0fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2432506436","title":"Kymera Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报35.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432506436","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432506436?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:28","pubTimestamp":1714573709,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时28分，Kymera Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012228307925a1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012228307925a1f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","KYMR"],"gpt_icon":0},{"id":"2431913378","title":"Kymera Therapeutics Inc    预计每股亏损 73 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431913378","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431913378?lang=zh_cn&edition=full","pubTime":"2024-04-30 23:00","pubTimestamp":1714489210,"startTime":"0","endTime":"0","summary":"   * Kymera Therapeutics Inc    将于5月2日公布截至2024年3月31日的财报，预计季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司的营收有望从去年同期的947万美元增长44.6%，达到1368.7万美元。* LSEG分析师对Kymera Therapeutics Inc的平均预期为每股亏损73美分。* 华尔街对Kymera Therapeutics Inc的12个月目标价中位数为45.50美元，高于其最新收盘价34.66美元。4月30日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","LENZ"],"gpt_icon":0},{"id":"2430028997","title":"Kymera Therapeutics, Inc.盘中异动 早盘快速下跌5.20%报33.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430028997","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430028997?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:41","pubTimestamp":1714052481,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时41分，Kymera Therapeutics, Inc.股票出现异动，股价急速下挫5.20%。Kymera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Kymera Therapeutics, Inc.公司简介：Kymera Therapeutics Inc是一家生物技术公司，开创了一种变革性的新方法来治疗以前无法治愈的疾病。Kymera的Pegasus靶向蛋白质降解平台利用人体的天然蛋白质回收机制降解致病蛋白质，重点关注常规药物目前无法通过的有效途径中的非药物节点。该信息摘要如下：Kymera Therapeutics获奥本海默首次覆盖，给予优于大市评级, 目标价53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252141227923767d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYMR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kymeratx.com","stockEarnings":[{"period":"1week","weight":0.0334},{"period":"1month","weight":0.4901},{"period":"3month","weight":0.3347},{"period":"6month","weight":0.4358},{"period":"1year","weight":1.0099},{"period":"ytd","weight":0.7494}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kymera Therapeutics, Inc.，一家根据特拉华州法律于2017年5月25日成立的有限责任公司。该公司是一家生物制药公司，致力于发现和开发新颖的小分子疗法，该疗法可通过利用药物选择性地降解致病蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.111455},{"month":2,"riseRate":0.25,"avgChangeRate":-0.034182},{"month":3,"riseRate":0.25,"avgChangeRate":-0.060002},{"month":4,"riseRate":0.5,"avgChangeRate":-0.04657},{"month":5,"riseRate":0.25,"avgChangeRate":-0.150138},{"month":6,"riseRate":0.5,"avgChangeRate":0.024718},{"month":7,"riseRate":0.75,"avgChangeRate":0.200878},{"month":8,"riseRate":0.666667,"avgChangeRate":0.062616},{"month":9,"riseRate":0.25,"avgChangeRate":-0.135819},{"month":10,"riseRate":0.75,"avgChangeRate":0.087377},{"month":11,"riseRate":0.5,"avgChangeRate":0.243236},{"month":12,"riseRate":0.75,"avgChangeRate":0.140141}],"exchange":"NASDAQ","name":"Kymera Therapeutics, Inc.","nameEN":"Kymera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kymera Therapeutics, Inc.(KYMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kymera Therapeutics, Inc.,KYMR,Kymera Therapeutics, Inc.股票,Kymera Therapeutics, Inc.股票老虎,Kymera Therapeutics, Inc.股票老虎国际,Kymera Therapeutics, Inc.行情,Kymera Therapeutics, Inc.股票行情,Kymera Therapeutics, Inc.股价,Kymera Therapeutics, Inc.股市,Kymera Therapeutics, Inc.股票价格,Kymera Therapeutics, Inc.股票交易,Kymera Therapeutics, Inc.股票购买,Kymera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kymera Therapeutics, Inc.(KYMR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kymera Therapeutics, Inc.(KYMR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}